OOIR: Observatory of International Research

Papers

(The median citation count of Heart Failure Clinics is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Unusual Forms of Pulmonary Hypertension	66
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	30
Genetic Risk Stratification in Arrhythmogenic Left Ventricular Cardiomyopathy	28
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	27
When all Else Fails, Try This	25
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	25
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	23
Forthcoming Issues	21
Changing Landscape of Heart Failure Imaging	21
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	20
Contents	20
Emerging Targeted Therapies for Inherited Cardiomyopathies and Arrhythmias	19
Therapy-Related Clonal Hematopoiesis	18
Genetic Determinants of Response to P2Y12 Inhibitors and Clinical Implications	17
Contributors	17
Contributors	17
Pharmacologic and Lifestyle Interventions to Modulate the Epigenome in Heart Failure	16
Genetics of High-Altitude Pulmonary Edema	16
Mitral Regurgitation	15
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	14
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	14
Contributors	13
Preload Reduction Therapies in Heart Failure	13
Patient Selection, Referral Timing, and Advanced Heart Disease Therapy Options for Heart Failure with Reduced Ejection Fraction	13
Arrhythmias in Adult Congenital Heart Disease Heart Failure	13

The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	12
Contributors	12
Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	12
What Is New in Risk Assessment in Nuclear Cardiology?	12
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	12
Copyright	11
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	11
Heart Failure Clinics	11
Myocardial Dysfunction in Patients with Cancer	10
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	10
Arrythmia-Mediated Valvular Heart Disease	10
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	9
Guide to Temporary Mechanical Support in Cardiogenic Shock	9
Cardiac Amyloidosis	9
Coronary Angiography in the Evaluation of Systolic Heart Failure	9
Shifting the Epigenetic and Multi-Omic Frontier to Get the Heart in Top Gear	9
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	9
SGLT2 Inhibitors in Heart Failure	9
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	8
Application of 3D Printing Technology in Heart Failure	8
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	8
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	8
Cardiac Contractility Modulation	7
Noncoding RNAs in Pulmonary Arterial Hypertension	7
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	7
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	6
Epigenetics of Heart Failure	6
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	6
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	6
Contents	6
Contributors	6
Copyright	6
Contents	6
Preface	6
Contents	6
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	6
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	6
Aortic Valvular Stenosis and Heart Failure	5
Contents	5
Contents	5
Copyright	5
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Adults with Congenital Heart Disease and Transplant	5
Remote Monitoring Devices and Heart Failure	4
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	4
The Role of Medical Therapy in Hypertrophic Cardiomyopathy	4
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	4
Clinical Practice Guidelines in Cardio-Oncology	4
SGLT2 Inhibitors and Peripheral Vascular Events	4
Pathophysiology of Cardiac Amyloidosis	3

Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?	3
Contributors	3
Mechanical Complication of Acute Myocardial Infarction Secondary to COVID-19 Disease	3
The Risk of Sudden Unexpected Cardiac Death in Children	3
Advances in the Therapy of Light Chain Cardiac Amyloidosis	3
Forthcoming Issues	3
Clinical Value of Positron Emission Tomography Myocardial Perfusion Imaging and Blood Flow Quantification	3
Clinical Use of Biomarkers in Cardiac Amyloidosis	3
Risk Factors for Progression in Hypertrophic Cardiomyopathy	3
Contributors	3
Forthcoming Issues	3
Contributors	3
Coronary Microvascular Dysfunction	3
Novel Non-pharmacological Approaches to Heart Failure	3
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19	2
Clinical and Molecular Aspects of Naxos Disease	2
Contents	2
Adult Congenital Heart Disease	2
Multimodality Imaging in the Evaluation of Hypertrophic Cardiomyopathy	2
Latest Updates in Heart Failure Imaging	2
Epidemiology, Pathogenesis, and Clinical Course of Takotsubo Syndrome	2
Contributors	2
Nuclear Cardiology	2
Copyright	2
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension	2
Contents	2
Changing Landscape of Heart Failure Imaging	2
Heart Failure Staging and Indications for Advanced Therapies in Adults with Congenital Heart Disease	2
Pulmonary Hypertension in Adult Congenital Heart Disease–Related Heart Failure	2
Copyright	2
Genetics of Thoracic and Thoracoabdominal Aortic Dissections and Aneurysms	2
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification	2
Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies	2
Translational Cardio-Oncology Research to Promote Better Outcomes for One and All	2
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination	2
Mechanical Circulatory Support in COVID-19	2
Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk	2
Forthcoming Issues	2
Copyright	2
Novel Approaches to Sleep Apnea in Heart Failure	2
Multiomics Insights into Epigenetic Mechanisms and Their Role as Biomarkers for Acute Coronary Syndrome	2
Epigenetic Regulation in Dilated Cardiomyopathy	2
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies	2
Multimodality Imaging in Aortic Stenosis	1
Extracardiac Prothrombotic Effects of COVID-19	1
Cardiopulmonary Exercise Testing in Research	1
Cardiac PET Imaging for Coronary Artery Disease and Heart Failure	1
Radionuclide Assessment of Sarcoidosis	1
Challenges in Pulmonary Hypertension	1
Monitoring for Valve Decrepitude: Surveillance Echo for All at Age 60…?	1
Contents	1
SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction	1
How to Start an Invasive Cardiopulmonary Exercise Testing Program	1
Translational Research in Cardio-Oncology	1
Copyright	1
Surgical Revascularization Decisions in Ischemia and Heart Failure	1
Obesity in Heart Failure with Reduced Ejection Fraction	1
SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction	1
Using Artificial Intelligence to Better Predict and Develop Biomarkers	1
Copyright	1
Valvular Heart Failure due to Tricuspid Regurgitation	1
Pediatric and Familial Genetic Arrhythmia Syndromes	1
Use and Prognostic Implications of Cardiac Troponin in COVID-19	1
Challenges in Pulmonary Hypertension	1
Contributors	1
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension	1
Forthcoming Issues	1
Novel PET Applications and Radiotracers for Imaging Cardiovascular Pathophysiology	1
Contributors	1
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease	1
Radionuclide Imaging of Infective Endocarditis	1
Amyloidosis and Amyloidogenesis	1
Forthcoming Issues	1
The Influence of Genotype on the Phenotype, Clinical Course, and Risk of Adverse Events in Children with Hypertrophic Cardiomyopathy	0
Utilizing Artificial Intelligence to Enhance Health Equity Among Patients with Heart Failure	0
Hypertrophic Cardiomyopathy in RASopathies	0
Contributors	0
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology	0
Contents	0
Copyright	0

PET Imaging for Cardiomyopathy Challenges Simplistic Notions of Ischemia and Viability	0
Intracellular Signaling Pathways Mediating Tyrosine Kinase Inhibitor Cardiotoxicity	0
Strategy for Exercise Restriction in Hypertrophic Cardiomyopathy	0
Hypertrophic Cardiomyopathy in the Absence of “Hypertrophy”	0
Contents	0
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis	0
Baroreflex Activation Therapy in Patients with Heart Failure with a Reduced Ejection Fraction	0
The Economic Burden of Heart Failure with Reduced Ejection Fraction	0
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension	0
Forthcoming Issues	0
The Emerging Role of Artificial Intelligence in Valvular Heart Disease	0
Viability and Congestive Heart Failure	0
Forthcoming Issues	0
Forthcoming Issues	0
Primary Mitral Regurgitation and Heart Failure	0
SGLT2 Inhibitors Are Lifesavers in Heart Failure	0
Cardiac Amyloidosis	0
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice	0
Secondary Mitral Regurgitation and Heart Failure	0
Genetics in Congenital Heart Diseases	0
SGLT-2 Inhibitors	0
Phenotyping the Many Faces of Hypertrophic Cardiomyopathy	0
Surgical Considerations in Adult Congenital Heart Disease Heart Failure	0
Copyright	0
Contents	0
Advances in Single-Photon Emission Computed Tomography	0
Immune Dysregulation in Ischemic Heart Disease Among Individuals with Human Immunodeficiency Virus	0
Copyright	0
Forthcoming Issues	0
Contents	0
Contents	0
Contributors	0
Copyright	0
Arrhythmic Stratification of Cardiac Amyloidosis	0
Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years	0
Failing with Cyanosis-Heart Failure in End-Stage Unrepaired or Partially Palliated Congenital Heart Disease	0
Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management	0
Oxygen Therapy in Pulmonary Vascular Disease	0
The Evolving Landscape of Hypertrophic Cardiomyopathy	0
Contents	0
Nuclear Cardiology in 2023	0
Contributors	0
Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension	0
Evaluation of Coronary Artery Disease and Ischemia by Cardiac Magnetic Resonance Imaging	0
Contents	0
Impact of Coronavirus Disease 2019 Pandemic on Cardiac Arrest and Emergency Care	0
The Arrhythmic Phenotype in Cardiomyopathy	0
The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy	0
Clinical Manifestations of 22q11.2 Deletion Syndrome	0
Covid-19	0
Cardioprotection of High-Risk Individuals	0
Heart Failure Preserved Ejection Fraction in Women	0
Coronary Artery Disease and Heart Failure—Continued Significant Morbidity and Mortality Highlights Need for Comprehensive Evaluation to Individualize Patient Management	0
Training and Career Development in Cardio-Oncology Translational and Implementation Science	0
Cardiovascular Effects of COVID-19	0
Approach to Ventricular Arrhythmias in Heart Failure	0
Interatrial Shunt Devices	0
Machine Learning in Cardiovascular Imaging	0
Forthcoming Issues	0
Forthcoming Issues	0
Forthcoming Issues	0
New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia	0
Optimizing Patient Selection, Referral Timing, and Advanced Therapies in Cardiogenic Shock	0
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis	0
Contributors	0
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events	0
Valvular Heart Disease and Heart Failure	0
Artificial Intelligence and Mechanical Circulatory Support	0
Cardiopulmonary Exercise Testing in Pulmonary Hypertension	0
Amyloid Cardiomyopathies: Clinical, Diagnostic and Therapeutic Aspects	0
Epigenetic Therapeutics in Human Heart Failure	0
Tricuspid Regurgitation and Right Heart Failure	0
Evaluation of Coronary Artery Disease and Ischemia by Echocardiography	0
Contributors	0
Copyright	0
Contents	0
Copyright	0
Standard Therapy in Cardiac Amyloidosis	0
Cardiac Implantable Electronic Devices in Ischemic Cardiomyopathy	0
Navigating the Evolving Landscape of Hypertrophic Cardiomyopathy	0
The Ability of Near-Infrared Spectroscopy to Identify Vulnerable Patients and Plaques: A Systematic Review and Meta-Analysis	0
The War Against Heart Failure Hospitalizations	0
Sudden Death Risk Assessment in Hypertrophic Cardiomyopathy Across the Lifespan	0
Pregnancy and Pulmonary Hypertension	0
Palliative Care in Adult Congenital Heart Disease–Associated Advanced Heart Disease	0
Heart Failure with Reduced Ejection Fraction	0
Utilizing Conversational Artificial Intelligence, Voice, and Phonocardiography Analytics in Heart Failure Care	0
Cardiopulmonary Exercise Testing, Rehabilitation, and Exercise Training in Postpulmonary Embolism	0
Contributors	0
Renoprotective Effects of SGLT2 Inhibitors	0
Framework for Digital Health Phenotypes in Heart Failure	0
Radionuclide Imaging of Heart-Brain Connections	0
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis	0
Stress-First Myocardial Perfusion Imaging	0
Exercise Testing in Elite Athletes	0